LINC02038

Across TCGA pan-cancer cohorts, LINC02038 RNA differs between tumor and matched normal tissue in 12 of 18 cancer types tested, making tumor–normal expression one of LINC02038’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where LINC02038 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC02038 is over-expressed in tumor, although a few such as KIRC and COAD show the opposite, repressed pattern.

KIRC, COAD, and KICH are the cancer types where LINC02038 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02038 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	II,III,IV	−2.064	<.001	12	view →
COAD	All	IV	−1.838	<.001	12	view →
KICH	Male	All	−2.881	<.001	11	view →
LUSC	All	III,IV	−2.445	<.001	9	view →
LUAD	Female	III,IV	−1.960	<.001	9	view →
KIRP	All	All	−1.090	<.001	6	view →
LIHC	All	All	+0.297	.001	6	view →
PAAD	Male	All	+1.125	.039	4	view →
READ	All	II,III,IV	−1.710	.020	2	view →
CHOL	All	All	+1.532	.001	2	view →
STAD	All	IV	−1.333	.016	1	view →
BLCA	Female	III,IV	+1.319	.014	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 12 lineages.

LINC02038–KIRC

Open the KIRC breakdown →